Article
Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement.
European journal of clinical pharmacology - 1 Oct 2013
Tan Sheng-Lan, Li Zhi, Zhang Wei, Song Guo-Bao, Liu Li-Ming, Peng Juan, Liu Zhao-Qian, Fan Lan, Meng Xiang-Guang, Wang Lian-Sheng, Chen Yao, Zhou Xin-Min, Zhou Hong-Hao
Abstract excerpt
PURPOSE: To investigate the influence of cytochrome P450 oxidoreductase (POR) polymorphisms (A503V and rs2868177) on warfarin stable dosage (WSD) in Han-Chinese patients with mechanical heart valve replacement (MHVR). METHODS: Three hundred and seventeen Han-Chinese MHVR patients on stable maintenance dose of warfarin were enrolled. Blood samples were collected for genotyping analyses of VKORC1 -1639G>A, CYP2C9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
